The University of Southampton
University of Southampton Institutional Repository

The relationship between regional pain with or without neuropathic symptoms and chronic widespread pain

The relationship between regional pain with or without neuropathic symptoms and chronic widespread pain
The relationship between regional pain with or without neuropathic symptoms and chronic widespread pain
This study was performed to test whether the risk of developing chronic widespread pain (CWP) in those with regional pain was augmented in those with symptoms of neuropathic pain (NP). Persons free of CWP completed the Douleur Neuropathique 4 (scores ≥3 indicating NP); demographics; Hospital Anxiety and Depression scale; Pittsburgh Sleep Quality Index; and pain medications. Participants were classified as having no pain, regional pain with no symptoms of NP (), or regional pain with symptoms of NP (NP). At the 12-month follow-up, participants with CWP were identified. Logistic regression estimated the odds ratio, with 95% confidence intervals, of CWP in the and NP groups compared with no pain, and NP compared with . Partial population attributable risks estimated the proportion of CWP attributable to baseline or NP exposure. One thousand one hundred sixty-two participants completed the baseline DN4 and provided pain data at follow-up: 523 (45.0%) had no baseline pain, 562 (48.4%) , and 77 (6.6%) NP. One hundred fifty-three (13.2%) had CWP at 12 months: 19 (3.6%) no pain, 108 (19.2%) , and 26 (33.8%) NP. (2.9 [1.9-4.3]) and NP (2.1 [1.1-4.0]) predicted CWP after adjusting for demographics, Hospital Anxiety and Depression scale, Pittsburgh Sleep Quality Index, and medications. The partial population attributable risk was 41.3% (25.2-54.0) for and 6.0% (0.1-11.6) for NP. The NP group were not more likely to develop CWP when compared directly with (1.5 [0.8-2.8]). Neuropathic pain was relatively rare and predicted a small number of new-onset CWP cases. Using these estimates, treatments targeting NP would at best prevent 6% of CWP cases.
0304-3959
1817-1823
McBeth, John
98012716-66ba-480b-9e43-ac53b51dce61
Mulvey, Matthew R.
b2e733fa-1466-4e38-8567-70c4f79788b0
Rashid, Amir
5bd0980d-42da-4e8b-a9f8-e4f99c1fa3ce
Anderson, James
71afbf8e-2bb0-439e-b680-2a5618ac2e94
Druce, Katie
89b491ff-014d-4746-9991-791887bed988
McBeth, John
98012716-66ba-480b-9e43-ac53b51dce61
Mulvey, Matthew R.
b2e733fa-1466-4e38-8567-70c4f79788b0
Rashid, Amir
5bd0980d-42da-4e8b-a9f8-e4f99c1fa3ce
Anderson, James
71afbf8e-2bb0-439e-b680-2a5618ac2e94
Druce, Katie
89b491ff-014d-4746-9991-791887bed988

McBeth, John, Mulvey, Matthew R., Rashid, Amir, Anderson, James and Druce, Katie (2019) The relationship between regional pain with or without neuropathic symptoms and chronic widespread pain. Pain, 160 (8), 1817-1823. (doi:10.1097/j.pain.0000000000001568).

Record type: Article

Abstract

This study was performed to test whether the risk of developing chronic widespread pain (CWP) in those with regional pain was augmented in those with symptoms of neuropathic pain (NP). Persons free of CWP completed the Douleur Neuropathique 4 (scores ≥3 indicating NP); demographics; Hospital Anxiety and Depression scale; Pittsburgh Sleep Quality Index; and pain medications. Participants were classified as having no pain, regional pain with no symptoms of NP (), or regional pain with symptoms of NP (NP). At the 12-month follow-up, participants with CWP were identified. Logistic regression estimated the odds ratio, with 95% confidence intervals, of CWP in the and NP groups compared with no pain, and NP compared with . Partial population attributable risks estimated the proportion of CWP attributable to baseline or NP exposure. One thousand one hundred sixty-two participants completed the baseline DN4 and provided pain data at follow-up: 523 (45.0%) had no baseline pain, 562 (48.4%) , and 77 (6.6%) NP. One hundred fifty-three (13.2%) had CWP at 12 months: 19 (3.6%) no pain, 108 (19.2%) , and 26 (33.8%) NP. (2.9 [1.9-4.3]) and NP (2.1 [1.1-4.0]) predicted CWP after adjusting for demographics, Hospital Anxiety and Depression scale, Pittsburgh Sleep Quality Index, and medications. The partial population attributable risk was 41.3% (25.2-54.0) for and 6.0% (0.1-11.6) for NP. The NP group were not more likely to develop CWP when compared directly with (1.5 [0.8-2.8]). Neuropathic pain was relatively rare and predicted a small number of new-onset CWP cases. Using these estimates, treatments targeting NP would at best prevent 6% of CWP cases.

This record has no associated files available for download.

More information

Published date: August 2019

Identifiers

Local EPrints ID: 491478
URI: http://eprints.soton.ac.uk/id/eprint/491478
ISSN: 0304-3959
PURE UUID: ba901467-5e75-4009-81a2-b3ffdfb937fa
ORCID for John McBeth: ORCID iD orcid.org/0000-0001-7047-2183

Catalogue record

Date deposited: 25 Jun 2024 16:31
Last modified: 26 Jun 2024 02:11

Export record

Altmetrics

Contributors

Author: John McBeth ORCID iD
Author: Matthew R. Mulvey
Author: Amir Rashid
Author: James Anderson
Author: Katie Druce

Download statistics

Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.

View more statistics

Atom RSS 1.0 RSS 2.0

Contact ePrints Soton: eprints@soton.ac.uk

ePrints Soton supports OAI 2.0 with a base URL of http://eprints.soton.ac.uk/cgi/oai2

This repository has been built using EPrints software, developed at the University of Southampton, but available to everyone to use.

We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we will assume that you are happy to receive cookies on the University of Southampton website.

×